» Authors » Margaret OMalley

Margaret OMalley

Explore the profile of Margaret OMalley including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 314
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mejia Perez L, OMalley M, Chatterjee A, Lyu R, Yang Q, Cruise M, et al.
Fam Cancer . 2024 Sep; 23(4):617-626. PMID: 39261344
To determine the preoperative detection of signet ring cancer cells (SRC) on upper endoscopy (EGD) in patients with CDH1 pathogenic variant (PV) undergoing gastrectomy. To evaluate the development of advanced...
2.
Banerjee S, Burke C, Sommovilla J, Anderson C, OMalley M, LaGuardia L, et al.
Dis Colon Rectum . 2023 Dec; 67(3):427-434. PMID: 38064246
Background: Prophylactic surgery for familial adenomatous polyposis has evolved over several decades. Restorative proctocolectomy with IPAA provides an alternative to total abdominal colectomy with ileorectal anastomosis. We have previously shown...
3.
Hajj Ali A, Burke C, OMalley M, LaGuardia L, Liska D, Macaron C
J Clin Gastroenterol . 2023 Aug; 58(6):596-601. PMID: 37646505
Background: Colonic polyposis of unknown etiology (CPUE) is defined as ≥10 cumulative colonic adenomas without a detectable germline pathogenic variant. Surveillance for patients with >100 adenomas is recommended, similar to...
4.
Faisal M, Burke C, Liska D, Lightner A, Leach B, OMalley M, et al.
World J Clin Oncol . 2022 Feb; 13(1):49-61. PMID: 35116232
Background: Individuals with Lynch syndrome (LS) and hereditary non-polyposis colorectal cancer (HNPCC) are at increased risk of both colorectal cancer and other cancers. The interplay between immunosuppression, a comorbid inflammatory...
5.
Chouhan H, Abbass M, Hrabe J, Ferrandon S, DeVecchio J, Mankaney G, et al.
Dis Colon Rectum . 2021 Dec; 65(1):40-45. PMID: 34882627
Background: Approximately 5% to 10% of patients with Lynch syndrome develop urothelial carcinoma. Current screening recommendations vary and are based on expert opinion. Practices need to be evaluated for clinical...
6.
Khare A, Burke C, Heald B, OMalley M, LaGuardia L, Milicia S, et al.
J Clin Gastroenterol . 2021 Jul; 56(3):e183-e188. PMID: 34231499
Goals And Background: Phosphatase and tensin homolog hamartoma tumor syndrome (PHTS) is an inherited disorder that increases the risk for cancer in multiple organ systems, including breast, endometrial, thyroid, and...
7.
Faisal M, Burke C, Achkar J, Click B, OMalley M, LaGuardia L, et al.
Fam Cancer . 2021 Apr; 21(2):189-195. PMID: 33822277
Clinicians may be hesitant to prescribe biologics or immunomodulators to individuals with familial adenomatous polyposis (FAP) and comorbid inflammatory disease (CID) because of increased cancer risk. Our aim was to...
8.
Mehta N, Shah R, Yoon J, OMalley M, LaGuardia L, Mankaney G, et al.
Clin Gastroenterol Hepatol . 2020 Jun; 19(4):760-767. PMID: 32492482
Background & Aims: Ampullary and duodenal cancer are the leading causes of death in patients with familial adenomatous polyposis (FAP) after colectomy has been performed. Risk of duodenal cancer is...
9.
Mankaney G, Cruise M, Sarvepalli S, Bhatt A, Arora Z, Baggot B, et al.
Gastrointest Endosc . 2020 May; 92(3):755-762. PMID: 32380015
Background And Aims: Gastric cancer is an extracolonic manifestation of familial adenomatous polyposis (FAP) and is associated with high-risk gastric polyps. There are no known endoscopic criteria to identify these...
10.
Nieminen T, Walker C, Olkinuora A, Genutis L, OMalley M, Wakely P, et al.
Thyroid . 2020 Feb; 30(3):380-388. PMID: 32024448
Familial adenomatous polyposis (FAP) is a condition typically caused by pathogenic germline mutations in the gene. In addition to colon polyps, individuals with FAP have a substantially increased risk of...